Pan-cancer profiles of mesothelin (MSLN) unveil diagnostic potential and therapeutic targetability of pancreatic adenocarcinoma
Md Ramjan Sheikh, Baishakhi Mistry, Ridika Haque Shafin, Amreeta Apu, Tasnia Hossain Sara, Jarin Tasnim, Dipankar Dutta, Aishwarya Nandy · 2026
Read Pan-cancer profiles of mesothelin (MSLN) unveil diagnostic potential and therapeutic targetability of pancreatic adenocarcinoma by Md Ramjan Sheikh, Baishakhi Mistry, Ridika Haque Shafin, Amreeta Apu, Tasnia Hossain Sara, Jarin Tasnim, Dipankar Dutta, Aishwarya Nandy (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/plos-pone-0354334.txt.
Description
Md Ramjan Sheikh and seven colleagues profile a cell-surface protein called mesothelin across many cancers in this 2026 study, with special attention to pancreatic cancer. The protein appears at high levels in several tumors but barely in most healthy tissue, which makes it attractive both for diagnosis and as a drug target. Using large public cancer datasets, the team mapped where it is switched on and what that means for patients.
Mesothelin ran high in pancreatic, ovarian, and mesothelioma tumors, and it distinguished pancreatic cancer from healthy tissue with high accuracy. Its value for predicting survival depended on the cancer type, and few tumors carried mutations in the gene itself. Computer modeling of candidate drugs singled out a plant-derived compound that bound the protein stably, though the authors caution that its predicted safety profile needs work before any real treatment use.
Catalog record
| CREATOR | Md Ramjan Sheikh, Baishakhi Mistry, Ridika Haque Shafin, Amreeta Apu, Tasnia Hossain Sara, Jarin Tasnim, Dipankar Dutta, Aishwarya Nandy |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 67986 |
| LICENSE | CC_BY |
| RIGHTS | CC BY |
| SOURCE | PLOS |